Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Curcumin for the Chemoprevention of Colorectal Cancer [NA]

View source ↗

Summary

Clinical trial NCT00118989 evaluating curcumin for chemoprevention of colorectal cancer was terminated. The study targeted patients with adenomatous polyps.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: University of Pennsylvania | Conditions: Adenomatous Polyps | NA | Status: TERMINATED